Study of HRS-9057 for fluid retention in heart failure
Part of Heart & circulation, Kidney & urinary clinical trials.
This trial tests an investigational drug, HRS-9057, in people hospitalized with heart failure who still have fluid buildup despite taking standard diuretics. The goal is to see if HRS-9057 helps remove excess fluid better than current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and admitted to the hospital for heart failure within the last 3 days.
- You have symptoms like shortness of breath or swelling, and a blood test shows high NT-proBNP or BNP levels.
- You have taken a certain amount of diuretic (water pill) in the past 12 hours but still have fluid retention.
- You do not have recent heart attack, stroke, or major surgery, and no severe kidney or liver problems.
- You are not pregnant, breastfeeding, or unable to follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral drug called HRS-7535 for people with a certain type of heart failure (where the heart pumps normally but doesn't relax properly) and who also have obesity. It aims to see if the drug can improve symptoms and daily function.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This trial tests a device to help the kidneys remove excess fluid in people hospitalized for worsening heart failure who are not responding well to standard diuretic (water pill) therapy. It aims to improve heart and kidney function.
This trial tests a device designed to safely remove extra fluid from patients hospitalized with worsening heart failure. It may help those who are not responding well to standard water pills (diuretics).
This trial tests a new way to manage fluid levels in people hospitalized for heart failure. It aims to help doctors adjust treatment to keep you from coming back to the hospital.
This trial tests an investigational medicine called CRD-4730 (taken as a pill) to see if it can improve heart function and symptoms in people with heart failure and a reduced pumping ability. It may help you feel better and slow the progression of your condition.
Hear when a new Fluid Retention Caused by Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.